Alexandre Grassin
Corporate Officer/Principal presso Calliditas Therapeutics Suisse SA
Posizioni attive di Alexandre Grassin
Società | Posizione | Inizio | Fine |
---|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
Direttore Amministrativo | 04/01/2012 | - | |
Direttore Finanziario/CFO | 04/01/2012 | 14/01/2015 |
Storia della carriera di Alexandre Grassin
Precedenti posizioni note di Alexandre Grassin
Società | Posizione | Inizio | Fine |
---|---|---|---|
ENGENE HOLDINGS INC. | Direttore Finanziario/CFO | 01/07/2023 | 29/11/2023 |
Alexion Pharma GmbH | Corporate Officer/Principal | 01/01/2010 | 01/01/2012 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2007 | 01/01/2010 |
GENKYOTEX SA. | Direttore Amministrativo | 01/04/2012 | - |
Direttore Finanziario/CFO | 01/04/2012 | - | |
KPMG SA
KPMG SA Miscellaneous Commercial ServicesCommercial Services KPMG SA provides auditing and accounting solutions. It intervenes in the insurance, asset management, real estate, automobile, and telecommunications sectors. The firm offers risk advisory, tax and regulatory, and financial advisory services. The company was founded in 1986 and is headquartered in Paris, France. | Corporate Officer/Principal | 01/01/2001 | - |
Statistiche
Distribuzione geografica
Svizzera | 4 |
Francia | 3 |
Canada | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Director of Finance/CFO | 3 |
Chief Administrative Officer | 2 |
Settori
Health Technology | 5 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
NOVARTIS AG | Health Technology |
ENGENE HOLDINGS INC. | Health Technology |
Aziende private | 4 |
---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
KPMG SA
KPMG SA Miscellaneous Commercial ServicesCommercial Services KPMG SA provides auditing and accounting solutions. It intervenes in the insurance, asset management, real estate, automobile, and telecommunications sectors. The firm offers risk advisory, tax and regulatory, and financial advisory services. The company was founded in 1986 and is headquartered in Paris, France. | Commercial Services |
Alexion Pharma GmbH | |
Calliditas Therapeutics France SAS
Calliditas Therapeutics France SAS Pharmaceuticals: MajorHealth Technology Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France. | Health Technology |
- Borsa valori
- Insiders
- Alexandre Grassin
- Esperienza